Principal Financial Group Inc Night Hawk Biosciences, Inc. Transaction History

Principal Financial Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.65 - $3.13 $35,296 - $66,956	-21,392 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$2.1 - $3.54 $22,770 - $38,384	-10,843 Reduced 33.64%	21,392 $65,000
Q4 2021 Feb 09, 2022	SELL	$3.04 - $6.01 $299,692 - $592,483	-98,583 Reduced 75.36%	32,235 $98,000
Q3 2021 Nov 09, 2021	SELL	$5.9 - $7.44 $10,325 - $13,020	-1,750 Reduced 1.32%	130,818 $778,000
Q2 2021 Aug 10, 2021	SELL	$5.78 - $9.6 $113,877 - $189,139	-19,702 Reduced 12.94%	132,568 $892,000
Q1 2021 May 10, 2021	BUY	$5.67 - $12.54 $65,783 - $145,489	11,602 Added 8.25%	152,270 $1.11 Million
Q4 2020 Feb 08, 2021	BUY	$5.28 - $9.59 $742,727 - $1.35 Million	140,668 New	140,668 $754,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.